AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz-Torres, M. L.
Right arrow Articles by Mullany, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz-Torres, M. L.
Right arrow Articles by Mullany, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2003, p. 1430-1432, Vol. 47, No. 4
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.4.1430-1432.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Novel Tetracycline Resistance Determinant from the Oral Metagenome

M. L. Diaz-Torres,1 R. McNab,1,{dagger} D. A. Spratt,1 A. Villedieu,1 N. Hunt,2 M. Wilson,1 and P. Mullany1*

Department of Microbiology,1 Department of Orthodontics, Eastman Dental Institute, University College London, London, United Kingdom2

Received 7 October 2002/ Returned for modification 27 November 2002/ Accepted 23 January 2003

A major drawback of most studies on how bacteria become resistant to antibiotics is that they concentrate mainly on bacteria that can be cultivated in the laboratory. In the present study, we cloned part of the oral metagenome and isolated a novel tetracycline resistance gene, tet(37), which inactivates tetracycline.

* Corresponding author. Mailing address: Department of Microbiology, Eastman Dental Institute, University College London, 256 Gray's Inn Rd., London WC1X 8LD, United Kingdom. Phone: 44 0 20 7915 1223. Fax: 44 0 20 7915 1127. E-mail: p.mullany{at}eastman.ucl.ac.uk.

{dagger} Present address: GlaxoSmithKline Consumer Healthcare, Surrey, United Kingdom.

Antimicrobial Agents and Chemotherapy, April 2003, p. 1430-1432, Vol. 47, No. 4
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.4.1430-1432.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.